KCNQ3 - autosomal dominant benign neonatal seizures type 2

This test is available for the following conditions:

  • Conditions > Neurological > Febrile seizures

This product is also part of the following panels:

  • Epilepsy panel
  • Intellectual disability panel with genome wide CNV analysis
  • Mendelian inherited disorders panel with genome wide CNV analysis
  • Neurological pain disorders panel¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 602232
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 435

Gene

KCNQ3 - autosomal dominant benign neonatal seizures type 2

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 435

KCNQ3 - autosomal dominant benign neonatal seizures type 2



€ 435
Gene

SCN1A - generalized epilepsy with febrile seizures plus type 2 / familial febrile seizures-3A

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 517

SCN1A - generalized epilepsy with febrile seizures plus type 2 / familial febrile seizures-3A



€ 517

SCN1A - generalized epilepsy with febrile seizures plus type 2 / familial febrile seizures-3A

This test is available for the following conditions:

  • Conditions > Neurological > Febrile seizures

This product is also part of the following panels:

  • Epilepsy panel
  • Intellectual disability panel with genome wide CNV analysis
  • Mendelian inherited disorders panel with genome wide CNV analysis
  • Movement disorders panel

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 604403
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 517